Arbutus Biopharma (ABUS) EBT Margin Growth (5y) (2018 - 2026)
Arbutus Biopharma (ABUS) EBT Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arbutus Biopharma | 880.36 Mn | 785.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 86,999.00 |
| Dec 31, 2025 | 24,156.00 |
| Sep 30, 2025 | -22,980.00 |
| Jun 30, 2025 | 95,375.00 |
| Mar 31, 2025 | -46,095.00 |
| Dec 31, 2024 | 72,964.00 |
| Sep 30, 2024 | 163,587.00 |
| Jun 30, 2024 | 242,033.00 |
| Mar 31, 2024 | 225,028.00 |
| Dec 31, 2023 | 18,722.00 |
| Sep 30, 2023 | 138,031.00 |
| Jun 30, 2023 | -61,601.00 |
| Mar 31, 2023 | 99,180.00 |
| Dec 31, 2022 | 202,651.00 |
| Sep 30, 2022 | -12,683.00 |
| Jun 30, 2022 | 165,732.00 |
| Mar 31, 2022 | 755,810.00 |
| Dec 31, 2021 | 13.21 Mn |
| Sep 30, 2021 | 195,806.00 |
| Jun 30, 2021 | 6.22 Mn |